Bromantane (Ladasten)

Bromantane (Ladasten) - innovative drugs for the treatment of asthenic conditions of different origins caused by mental stress, fatigue, lack of sleep, various infectious and somatic diseases.

Bromantane main mechanisms of action are increased synthesis and release of dopamine, as well as improvement of impaired stress GABA reception

Bromantane

Eliminates daytime sleepiness, increases the activity, improves concentration and performance

Almost does not cause phenomena hyperstimulation (sleep disorders, anxiety, amplification)

Therapeutic effect Bromantane develops quickly - the first taking the drug

A balanced combination of psychostimulant and anxiolytic action component can effectively act on all of the major manifestations of asthenic syndrome (actually asthenia, anxiety and autonomic symptoms)

It does not cause-effect phenomena typical of stimulants associated with the depletion of neuronal catecholamine reserves.

Bromantane has not have behavioral toxicity that allows to recommend its use, including, and motorists

Bromantane acts quickly, comprehensively affects all manifestations of fatigue. This Ladasten does not cause excessive stimulation of addiction and dependence.

Efficiency Bromantane the treatment of asthenic conditions of different genesis proven in clinical studies, including randomized, placebo-controlled studies

Bromantane developed in the Research Institute of Pharmacology. VV Zakusov RAMS. Complex Bromantane comprehensive study was conducted in the period from 1980 to 2000-ies. After conducting clinical studies that proved Bromantane efficacy and safety in the treatment of asthenic disorders, in 2008, the drug has been registered for use in Russia.